Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 15, 2026Oct 16 8:35 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$546.65$5.2M324,443(I)

View →

Oct 15, 2026Oct 16 8:34 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$544.30$4.5M45,172(D)

View →

Oct 14, 2026Oct 15 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$539.99$5.1M324,443(I)

View →

Oct 15, 2026Oct 15 8:22 PMPAUL MAHON
Proposed Sale
8,300$544.30$4.5M—

View →

Oct 13, 2026Oct 14 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$545.52$5.2M324,443(I)

View →

Oct 12, 2026Oct 13 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$550.70$5.2M324,443(I)

View →

Oct 9, 2026Oct 13 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$544.94$5.2M324,443(I)

View →

Oct 8, 2026Oct 9 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$534.31$5.1M324,443(I)

View →

Oct 7, 2026Oct 8 9:28 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$548.95$5.2M324,443(I)

View →

Oct 6, 2026Oct 7 8:35 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$538.67$5.1M324,443(I)

View →

Oct 5, 2026Oct 6 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$541.64$5.1M324,443(I)

View →

Oct 2, 2026Oct 5 8:53 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$549.37$5.2M324,443(I)

View →

Oct 1, 2026Oct 2 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$576.47$5.5M324,443(I)

View →

Oct 1, 2026Oct 1 9:30 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$564.95$4.7M45,172(D)

View →

Sep 30, 2026Oct 1 9:22 PMMartine A RothblattDirector, Chairperson & CEO
Sale
1,920$550.22$1.1M324,443(I)

View →

Sep 30, 2026Oct 1 9:20 PMMartine A RothblattDirector, Chairperson & CEO
Sale
7,580$517.97$3.9M326,363(I)

View →

Oct 1, 2026Oct 1 8:37 PMMARTINE ROTHBLATT
Proposed Sale
209,000$541.89$113.3M—

View →

Oct 1, 2026Oct 1 8:07 PMPAUL MAHON
Proposed Sale
8,300$564.95$4.7M—

View →

Sep 29, 2026Sep 30 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$477.42$4.5M324,443(I)

View →

Sep 28, 2026Sep 29 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$480.85$4.6M324,443(I)

View →

Page 1 of 22

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,220—1,220(D)

View →

← Previous

Page 13 of 13